Exane Derivatives’s Progressive PGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$490K Sell
4,219
-4,423
-51% -$501K 0.28% 88
2022
Q1
$985K Buy
8,642
+1,746
+25% +$189K 0.28% 95
2021
Q4
$708K Buy
6,896
+170
+3% +$16.2K 0.17% 135
2021
Q3
$608K Buy
6,726
+966
+17% +$92.1K 0.15% 150
2021
Q2
$563K Buy
5,760
+274
+5% +$27.1K 0.13% 166
2021
Q1
$524K Sell
5,486
-21
-0.4% -$1.91K 0.15% 140
2020
Q4
$545K Buy
5,507
+5,478
+18,890% +$518K 0.16% 139
2020
Q3
$2.75K Hold
29
﹤0.01% 545
2020
Q2
$2.32K Hold
29
﹤0.01% 494
2020
Q1
$2.14K Hold
29
﹤0.01% 496
2019
Q4
$2.19K Hold
29
﹤0.01% 490
2019
Q3
$2.24K Hold
29
﹤0.01% 480
2019
Q2
$2.32K Hold
29
﹤0.01% 500
2019
Q1
$2.09K Hold
29
﹤0.01% 445
2018
Q4
$1.75K Sell
29
-1,905
-99% -$127K ﹤0.01% 532
2018
Q3
$137K Hold
1,934
0.03% 287
2018
Q2
$114K Hold
1,934
0.02% 314
2018
Q1
$117K Buy
1,934
+94
+5% +$5.37K 0.02% 282
2017
Q4
$104K Buy
+1,840
New +$95.2K 0.02% 294

Other funds holding PGR

Exane Derivatives's PGR Position: Q2 2022 in Review

Exane Derivatives reduced its Progressive (PGR) stake by 51% in Q2 2022, selling an estimated $501K and leaving 4,219 shares worth $490K. The position accounts for 0.28% of the portfolio, ranked #88.

Exane Derivatives first reported a position in PGR in Q4 2017 and has held it in 19 quarters since. The position peaked at $985K in Q1 2022. 1,083 funds tracked by Wall St. Rank hold PGR as of Q2 2022.

  • Exane Derivatives held 4,219 shares of Progressive worth $490K as of Q2 2022.
  • Exane Derivatives sold 4,423 Progressive shares in Q2 2022, an estimated $501K.
  • Progressive made up 0.28% of Exane Derivatives's portfolio in Q2 2022, its #88 holding.
  • Exane Derivatives first reported a position in Progressive in Q4 2017 and has held it in 19 quarters since.
  • Exane Derivatives's Progressive position peaked at $985K in Q1 2022.
  • 1,083 funds tracked by Wall St. Rank held Progressive as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.